Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure.
about
Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Development of a physiological ...... orphisms on itopride exposure.
@en
Development of a physiological ...... vin-containing monooxygenase 3
@nl
type
label
Development of a physiological ...... orphisms on itopride exposure.
@en
Development of a physiological ...... vin-containing monooxygenase 3
@nl
prefLabel
Development of a physiological ...... orphisms on itopride exposure.
@en
Development of a physiological ...... vin-containing monooxygenase 3
@nl
P2093
P2860
P356
P1476
Development of a physiological ...... morphisms on itopride exposure
@en
P2093
Eric Masson
Helen Humphries
Iain Gardner
Nidal Al-Huniti
Wangda Zhou
P2860
P304
P356
10.1002/BDD.2074
P577
2017-05-28T00:00:00Z